Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria

Parasite Immunology

Volumn 32, Issue 3, 2010, Pages 193-201

  Osier, F H A ^a   Murungi, L M ^a   Fegan, G ^a,c   Tuju, J ^a   Tetteh, K K ^c   Bull, P C ^a   Conway, D J ^b,c   Marsh, K ^a  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Allele specific antibodies; Clinical malaria; Msp2 genotypes; Plasmodium falciparum

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; MEROZOITE SURFACE PROTEIN 2;

ALLELE; ANTIBODY SPECIFICITY; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HUMAN; IMMUNITY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ALLELES; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHILD, PRESCHOOL; DNA, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; INFANT; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PROTOZOAN PROTEINS;

PLASMODIUM FALCIPARUM;

EID: 76749114386     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2009.01178.x     Document Type: Article

References (31)

1. Contamin H, Fandeur T, Rogier C, et al. Different genetic characteristics of Plasmodium falciparum isolates collected during successive clinical malaria episodes in Senegalese children. Am J Trop Med Hyg 1996 54 : 632 643.
2. Covell G Nicol WD. Clinical, chemotherapeutic and immunological studies on induced malaria. Br Med Bull 1951 8 : 51 55.
3. Daubersies P, Sallenave-Sales S, Magne S, et al. Rapid turnover of Plasmodium falciparum populations in asymptomatic individuals living in a high transmission area. Am J Trop Med Hyg 1996 54 : 18 26.
4. McKenzie FE, Smith DL, O'Meara WP Riley EM. Chapter 1 strain theory of malaria the first 50 years. Adv Parasitol 2008 66 : 1 46.
5. Crewther PE, Matthew ML, Flegg RH Anders RF. Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes. Infect Immun 1996 64 : 3310 3317.
6. Renia L, Ling IT, Marussig M, et al. Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge. Infect Immun 1997 65 : 4419 4423.
7. Genton B, Betuela I, Felger I, et al. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J Infect Dis 2002 185 : 820 827.
8. Osier FH, Fegan G, Polley SD, et al. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun 2008 76 : 2240 2248.
9. Felger I, Steiger S, Hatz C, Smith T Beck HP. Antigenic cross-reactivity between different alleles of the Plasmodium falciparum merozoite surface protein 2. Parasite Immunol 2003 25 : 531 543.
10. Cheesman SJ, de Roode JC, Read AF Carter R. Real-time quantitative PCR for analysis of genetically mixed infections of malaria parasites: technique validation and applications. Mol Biochem Parasitol 2003 131 : 83 91.
11. Bozdech Z, Llinas M, Pulliam BL, et al. The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol 2003 1 : E5.
12. Salanti A, Staalsoe T, Lavstsen T, et al. Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol 2003 49 : 179 191.
13. Taylor RR, Allen SJ, Greenwood BM Riley EM. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am J Trop Med Hyg 1998 58 : 406 413.
14. Osier FH, Polley SD, Mwangi T, et al. Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3. Parasite Immunol 2007 29 : 387 394.
15. Metzger WG, Okenu DM, Cavanagh DR, et al. Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria. Parasite Immunol 2003 25 : 307 312.
16. Conway DJ Polley SD. Measuring immune selection. Parasitology 2002 125 (Suppl S3 S16.
17. Farnert A, Snounou G, Rooth I Bjorkman A. Daily dynamics of Plasmodium falciparum subpopulations in asymptomatic children in a holoendemic area. Am J Trop Med Hyg 1997 56 : 538 547.
18. Magesa SM, Mdira KY, Babiker HA, et al. Diversity of Plasmodium falciparum clones infecting children living in a holoendemic area in north-eastern Tanzania. Acta Trop 2002 84 : 83 92.
19. Ofosu-Okyere A, Mackinnon MJ, Sowa MP, et al. Novel Plasmodium falciparum clones and rising clone multiplicities are associated with the increase in malaria morbidity in Ghanaian children during the transition into the high transmission season. Parasitology 2001 123 : 113 123.
20. Lines J Armstrong JR. For a few parasites more: inoculum size, vector control and strain-specific immunity to malaria. Parasitol Today 1992 8 : 381 383.
21. Stanisic DI, Richards JS, McCallum FJ, et al. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Infect Immun 2009 77 : 1165 1174.
22. Kanunfre KA, Leoratti FM, Hoffmann EH, et al. Differential recognition of Plasmodium falciparum merozoite surface protein 2 variants by antibodies from malaria patients in Brazil. Clin Diagn Lab Immunol 2003 10 : 973 976.
23. Polley SD, Conway DJ, Cavanagh DR, et al. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Vaccine 2006 24 : 4233 4246.
24. Tami A, Grundmann H, Sutherland C, et al. Restricted genetic and antigenic diversity of Plasmodium falciparum under mesoendemic transmission in the Venezuelan Amazon. Parasitology 2002 124 : 569 581.
25. Ekala MT, Jouin H, Lekoulou F, Mercereau-Puijalon O Ntoumi F. Allelic family specific humoral responses to merozoite surface protein 2 (MSP2) in Gabonese residents with Plasmodium falciparum infections. Clin Exp Immunol 2002 129 : 326 331.
26. Weisman S, Wang L, Billman-Jacobe H, et al. Antibody responses to infections with strains of Plasmodium falciparum expressing diverse forms of merozoite surface protein 2. Infect Immun 2001 69 : 959 967. (Pubitemid 32109562)
27. Scopel KK, da Silva-Nunes M, Malafronte RS, Braga EM Ferreira MU. Variant-specific antibodies to merozoite surface protein 2 and clinical expression of Plasmodium falciparum malaria in rural Amazonians. Am J Trop Med Hyg 2007 76 : 1084 1091. (Pubitemid 351837870)
28. Franks S, Baton L, Tetteh K, et al. Genetic diversity and antigenic polymorphism in Plasmodium falciparum: extensive serological cross-reactivity between allelic variants of merozoite surface protein 2. Infect Immun 2003 71 : 3485 3495.
29. Akpogheneta OJ, Duah NO, Tetteh KK, et al. Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. Infect Immun 2008 76 : 1748 1755.
30. Kinyanjui SM, Conway DJ, Lanar DE Marsh K. IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar J 2007 6 : 82.
31. Low A, Chandrashekaran IR, Adda CG, et al. Merozoite surface protein 2 of Plasmodium falciparum: expression, structure, dynamics, and fibril formation of the conserved N-terminal domain. Biopolymers 2007 87 : 12 22.